Literature DB >> 22416996

Simvastatin interactions with other drugs.

Matilda Florentin1, Moses S Elisaf.   

Abstract

INTRODUCTION: Statins, the mainstay of lipid-lowering therapy, are among the most commonly used drugs due to their beneficial effects in cardiovascular morbidity and mortality. Simvastatin, one of the most well-studied statins, is available in several generic forms both as monotherapy and with ezetimibe and is frequently prescribed worldwide. Despite its overall favorable risk profile, several previously stated concerns regarding high-dose simvastatin were recently formalized by the Food and Drug Administration (FDA). AREAS COVERED: This paper discusses the interactions between simvastatin and other drugs and presents the latest FDA recommendations regarding the safe use of this statin. Relevant articles were identified through a PubMed search (up to December 2011). Furthermore, the latest FDA warning (June 2011) regarding simvastatin use was taken into account. EXPERT OPINION: Simvastatin may have serious side effects particularly when used in high doses and in combination with certain drugs. Physicians need to adjust the recent recommendations made by the FDA in clinical practice in order to prevent treatment complications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22416996     DOI: 10.1517/14740338.2012.670633

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  8 in total

Review 1.  Prevalence of statin-drug interactions in older people: a systematic review.

Authors:  Michele Thai; Emily Reeve; Sarah N Hilmer; Katie Qi; Sallie-Anne Pearson; Danijela Gnjidic
Journal:  Eur J Clin Pharmacol       Date:  2016-01-20       Impact factor: 2.953

2.  Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.

Authors:  Carolyn Hoppe; Eufemia Jacob; Lori Styles; Frans Kuypers; Sandra Larkin; Elliott Vichinsky
Journal:  Br J Haematol       Date:  2017-03-28       Impact factor: 6.998

3.  Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy.

Authors:  L M Camargo; C N França; M C Izar; H T Bianco; L S Lins; S P Barbosa; L F Pinheiro; F A H Fonseca
Journal:  Braz J Med Biol Res       Date:  2014-05-02       Impact factor: 2.590

4.  Comparative efficacy of pitavastatin and simvastatin in patients with hypercholesterolemia: a meta-analysis of randomized controlled clinical trials.

Authors:  Ning Ma; Lianqun Cui
Journal:  Drug Des Devel Ther       Date:  2015-03-31       Impact factor: 4.162

5.  Prevalence and Predictors of Statin Treatment Among Patients With Chronic Heart Failure at a Tertiary-Care Center in Thailand.

Authors:  Pattamawan Kosuma; Arom Jedsadayanmata
Journal:  Clin Med Insights Cardiol       Date:  2019-06-10

6.  A Retrospective Multisite Case-Control Series of Concomitant Use of Daptomycin and Statins and the Effect on Creatine Phosphokinase.

Authors:  Bethany Lehman; Elizabeth A Neuner; Victor Heh; Carlos Isada
Journal:  Open Forum Infect Dis       Date:  2019-11-07       Impact factor: 3.835

7.  DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels.

Authors:  Cheng Yan; Guihua Duan; Yi Pan; Fang-Xiang Wu; Jianxin Wang
Journal:  BMC Bioinformatics       Date:  2019-12-24       Impact factor: 3.169

8.  The Practice of the Community Pharmacists in Managing Potential Drug-Drug Interactions: A Simulated Patient Visits.

Authors:  Riham M Hamadouk; Esra D Albashair; Fatimah M Mohammed; Bashir A Yousef
Journal:  Integr Pharm Res Pract       Date:  2022-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.